Category Events

We will be present at BIO-Europe Spring for one-to-one meeting. https://informaconnect.com/bioeurope-spring/

The 3rd Immune-Oncology World Congress Immuno-Oncology2022 will focus on the latest developments and findings in immuno-oncology therapy as well as targeted therapy. The Congress will examine treatments available on the market as well as treatments still in the development stage. A poster of our work will be on display for the duration of the Congress.  

Immunology, looking to the future of medical sciences. The Thematic Meeting: « Immunology, looking to the future of medical sciences » is a major event for the immunology sector in the south of France. http://fr.ap-hm.fr/sites/default/files/files/221011_%20Programme%20-%20%20Immunology,%20looking%20to%20the%20future%20of%20medical%20science.pdf

Day of the cluster : Biotherapy Innovation Occitanie October 13, 2022 in Montpellier https://www.agence-adocc.com/biotherapie-innovation-occitanie/  

NanoMedSyn is co-organiser of  the 2nd Symposium on delivery and target for pediatric tumors, on 23-24th June in Switzerland (Schwarzsee). Our collaborative work and of the company have been presented.

10th Antibody Industrial Symposium 2022 We are proud to announce our participation to the 10th Antibody Industrial Symposium 2022 (AIS2022) that will be held from 28th to 29th June 2022 in person in Montpellier, France. https://aiscongress.com  

Henry-Vincent Charbonné (1953-2021)

NanoMedSyn is classified as a DEEPTECH company by Bpifrance for its Innovative Therapeutic Targeting Technology.

NanoMedSyn has signed a research agreement with the French National Research Agency within the framework of the « Plan France Relance Préservation de l’Emploi de R&D ». This agreement concerns a two-year collaborative research project with a CNRS institute in Montpellier, the Max Mousseron Institute of Biomolecules.

NanoMedSyn has been distinguished for its Growth Path by Bpifrance and joins the « Excellence » community.